Instil Bio, Inc.
TIL· Nasdaq
Released Nov 15, 2021, before the open
10-Q filed Nov 15, 2021, 46 days after period end · 0001789769-21-000067
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $0.00 | $52.00K |
| Net Income | -$43.01M | -$7.26M |
| EPS Diluted | -$0.33 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
+1.3% from the close of Nov 12, 2021 to the close of Nov 15, 2021, the first after the release.